BACKGROUND AND PURPOSE: American Indians have high rates of stroke. Improved risk stratification could enhance prevention, but the ability of biochemical and echocardiographic markers of preclinical disease to improve stroke prediction is not well-defined. METHODS: We evaluated such markers as predictors of ischemic stroke in a community-based cohort of American Indians without prevalent cardiovascular or renal disease. Laboratory markers included C-reactive protein, fibrinogen, urine albumin-to-creatinine ratio, and glycohemoglobin (HbA1c), whereas echocardiographic parameters comprised left atrial diameter, left ventricular mass, mitral annular calcification, and the ratio of early to late mitral diastolic velocities. Predictive performance was judged by indices of discrimination, reclassification, and calibration. RESULTS: After adjustment for standard risk factors, only HbA1c, albuminuria, and left atrial diameter were significantly associated with first ischemic stroke. Addition of HbA1c, although not urine albumin-to-creatinine ratio, to a basic clinical model significantly improved the C-statistic (0.714 versus 0.695; P=0.044), whereas left atrial diameter modestly enhanced integrated discrimination improvement (0.90%; P=0.004), but not the C-statistic (0.701; P=0.528). When combined with HbA1c, left atrial diameter further increased integrated discrimination improvement (1.81%; P<0.001) but not the C-statistic (0.716). No marker achieved significant net reclassification improvement. CONCLUSIONS: In this cohort at high cardiometabolic risk, HbA1c emerged as the foremost predictor of ischemic stroke when added to traditional risk factors, affording substantially improved discrimination, with a more modest contribution for left atrial diameter. These findings bolster the role of HbA1c in cardiovascular risk assessment among persons with glycometabolic disorders and provide impetus for further study of the incremental value of echocardiography in high-risk populations.
BACKGROUND AND PURPOSE: American Indians have high rates of stroke. Improved risk stratification could enhance prevention, but the ability of biochemical and echocardiographic markers of preclinical disease to improve stroke prediction is not well-defined. METHODS: We evaluated such markers as predictors of ischemic stroke in a community-based cohort of American Indians without prevalent cardiovascular or renal disease. Laboratory markers included C-reactive protein, fibrinogen, urine albumin-to-creatinine ratio, and glycohemoglobin (HbA1c), whereas echocardiographic parameters comprised left atrial diameter, left ventricular mass, mitral annular calcification, and the ratio of early to late mitral diastolic velocities. Predictive performance was judged by indices of discrimination, reclassification, and calibration. RESULTS: After adjustment for standard risk factors, only HbA1c, albuminuria, and left atrial diameter were significantly associated with first ischemic stroke. Addition of HbA1c, although not urine albumin-to-creatinine ratio, to a basic clinical model significantly improved the C-statistic (0.714 versus 0.695; P=0.044), whereas left atrial diameter modestly enhanced integrated discrimination improvement (0.90%; P=0.004), but not the C-statistic (0.701; P=0.528). When combined with HbA1c, left atrial diameter further increased integrated discrimination improvement (1.81%; P<0.001) but not the C-statistic (0.716). No marker achieved significant net reclassification improvement. CONCLUSIONS: In this cohort at high cardiometabolic risk, HbA1c emerged as the foremost predictor of ischemic stroke when added to traditional risk factors, affording substantially improved discrimination, with a more modest contribution for left atrial diameter. These findings bolster the role of HbA1c in cardiovascular risk assessment among persons with glycometabolic disorders and provide impetus for further study of the incremental value of echocardiography in high-risk populations.
Authors: E T Lee; T K Welty; R Fabsitz; L D Cowan; N A Le; A J Oopik; A J Cucchiara; P J Savage; B V Howard Journal: Am J Epidemiol Date: 1990-12 Impact factor: 4.897
Authors: A Ilercil; M J O'Grady; M J Roman; M Paranicas; E T Lee; T K Welty; R R Fabsitz; B V Howard; R B Devereux Journal: J Am Soc Echocardiogr Date: 2001-06 Impact factor: 5.251
Authors: Jonathan N Bella; Vittorio Palmieri; Mary J Roman; Jennifer E Liu; Thomas K Welty; Elisa T Lee; Richard R Fabsitz; Barbara V Howard; Richard B Devereux Journal: Circulation Date: 2002-04-23 Impact factor: 29.690
Authors: Viti Kothari; Richard J Stevens; Amanda I Adler; Irene M Stratton; Susan E Manley; H Andrew Neil; Rudy R Holman Journal: Stroke Date: 2002-07 Impact factor: 7.914
Authors: Caroline S Fox; Ramachandran S Vasan; Helen Parise; Daniel Levy; Christopher J O'Donnell; Ralph B D'Agostino; Emelia J Benjamin Journal: Circulation Date: 2003-03-25 Impact factor: 29.690
Authors: T K Welty; E T Lee; J Yeh; L D Cowan; O Go; R R Fabsitz; N A Le; A J Oopik; D C Robbins; B V Howard Journal: Am J Epidemiol Date: 1995-08-01 Impact factor: 4.897
Authors: Gernot Pichler; Maria Grau-Perez; Maria Tellez-Plaza; Jason Umans; Lyle Best; Shelley Cole; Walter Goessler; Kevin Francesconi; Jonathan Newman; Josep Redon; Richard Devereux; Ana Navas-Acien Journal: Circ Cardiovasc Imaging Date: 2019-05 Impact factor: 7.792
Authors: Khadijah Breathett; Mario Sims; Marie Gross; Elizabeth A Jackson; Emily J Jones; Ana Navas-Acien; Herman Taylor; Kevin L Thomas; Barbara V Howard Journal: Circulation Date: 2020-05-28 Impact factor: 29.690
Authors: Kevin Jordan; Shadi Yaghi; Athena Poppas; Andrew D Chang; Brian Mac Grory; Shawna Cutting; Tina Burton; Mahesh Jayaraman; Georgios Tsivgoulis; M Khaled Sabeh; Alexander E Merkler; Hooman Kamel; Mitchell S V Elkind; Karen Furie; Christopher Song Journal: Stroke Date: 2019-06-13 Impact factor: 7.914
Authors: Katherine A Moon; Ana Navas-Acien; Maria Grau-Pérez; Kevin A Francesconi; Walter Goessler; Eliseo Guallar; Jason G Umans; Lyle G Best; Jonathan D Newman Journal: PLoS One Date: 2017-08-03 Impact factor: 3.240
Authors: Wenyu Wang; Ying Zhang; Elisa T Lee; Barbara V Howard; Richard B Devereux; Shelley A Cole; Lyle G Best; Thomas K Welty; Everett Rhoades; Jeunliang Yeh; Tauqeer Ali; Jorge R Kizer; Hooman Kamel; Nawar Shara; David O Wiebers; Julie A Stoner Journal: World J Cardiovasc Dis Date: 2017-05-27
Authors: Jennifer S Lee; Po-Yin Chang; Ying Zhang; Jorge R Kizer; Lyle G Best; Barbara V Howard Journal: Diabetes Care Date: 2017-01-25 Impact factor: 19.112